Mouse Anti Human Macrophage (Tissue And Proliferative Disorders) Monoclonal Antibody |
DMABT-52185MH |
Creative Diagnostics |
0.5 ml |
EUR 1226.4 |
Human IgG antibody Laboratories manufactures the nervous system disorders of monoclonal igm reagents distributed by Genprice. The Nervous System Disorders Of Monoclonal Igm reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm monoclonal. Other Nervous products are available in stock. Specificity: Nervous Category: System Group: Disorders Of
Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit |
GenAsia Biotech |
96T |
EUR 559.2 |
human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit |
ChemNorm |
96T |
EUR 577.2 |
human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit |
ChemNorm |
48T |
EUR 398.4 |
Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit |
Qayee Biotechnology |
96T |
EUR 433.2 |
human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit |
Shanghai YL Biotech |
48T |
Ask for price |
human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit |
Shanghai YL Biotech |
96T |
Ask for price |
Mouse phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM |
Shanghai YL Biotech |
48T |
Ask for price |
Disorders Of information
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF594 conjugate, 0.1mg/mL |
BNC943793-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF488A conjugate, 0.1mg/mL |
BNC883792-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF488A conjugate, 0.1mg/mL |
BNC883792-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF488A conjugate, 0.1mg/mL |
BNC883793-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF488A conjugate, 0.1mg/mL |
BNC883793-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), Biotin conjugate, 0.1mg/mL |
BNCB3792-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), Biotin conjugate, 0.1mg/mL |
BNCB3792-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), Biotin conjugate, 0.1mg/mL |
BNCB3793-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), Biotin conjugate, 0.1mg/mL |
BNCB3793-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF640R conjugate, 0.1mg/mL |
BNC403792-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF640R conjugate, 0.1mg/mL |
BNC403792-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF640R conjugate, 0.1mg/mL |
BNC403793-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF640R conjugate, 0.1mg/mL |
BNC403793-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF405S conjugate, 0.1mg/mL |
BNC043792-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(rEPO/1367), CF405S conjugate, 0.1mg/mL |
BNC043792-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF405S conjugate, 0.1mg/mL |
BNC043793-100 |
Biotium |
1uL |
EUR 192 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Erythropoietin (EPO) (Marker of Placentation Disorders)(EPO/3793R), CF405S conjugate, 0.1mg/mL |
BNC043793-500 |
Biotium |
1uL |
EUR 532 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |